Inhibition of the Growth Factor MDK/Midkine by a Novel Small Molecule Compound to Treat Non-Small Cell Lung Cancer
Open Access
- 16 August 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (8) , e71093
Abstract
Midkine (MDK) is a heparin-binding growth factor that is highly expressed in many malignant tumors, including lung cancers. MDK activates the PI3K pathway and induces anti-apoptotic activity, in turn enhancing the survival of tumors. Therefore, the inhibition of MDK is considered a potential strategy for cancer therapy. In the present study, we demonstrate a novel small molecule compound (iMDK) that targets MDK. iMDK inhibited the cell growth of MDK-positive H441 lung adenocarcinoma cells that harbor an oncogenic KRAS mutation and H520 squamous cell lung cancer cells, both of which are types of untreatable lung cancer. However, iMDK did not reduce the cell viability of MDK-negative A549 lung adenocarcinoma cells or normal human lung fibroblast (NHLF) cells indicating its specificity. iMDK suppressed the endogenous expression of MDK but not that of other growth factors such as PTN or VEGF. iMDK suppressed the growth of H441 cells by inhibiting the PI3K pathway and inducing apoptosis. Systemic administration of iMDK significantly inhibited tumor growth in a xenograft mouse model in vivo. Inhibition of MDK with iMDK provides a potential therapeutic approach for the treatment of lung cancers that are driven by MDK.Keywords
This publication has 36 references indexed in Scilit:
- Genetic Changes in Squamous Cell Lung Cancer: A ReviewJournal of Thoracic Oncology, 2012
- Squamous Cell Carcinoma of the Lung: Molecular Subtypes and Therapeutic OpportunitiesClinical Cancer Research, 2012
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerNew England Journal of Medicine, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Midkine inhibitors: application of a simple assay procedure to screening of inhibitory compoundsInternational Archives of Medicine, 2010
- Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunctionCardiovascular Research, 2009
- Semaphorin3a regulates endothelial cell number and podocyte differentiation during glomerular developmentDevelopment, 2009
- Angiogenesis in pre-malignant conditionsEuropean Journal of Cancer, 2009
- Survivin Down-regulation Plays a Crucial Role in 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitor-induced Apoptosis in CancerJournal of Biological Chemistry, 2007
- Midkine, a newly discovered regulator of the renin–angiotensin pathway in mouse aorta: Significance of the pleiotrophin/midkine developmental gene family in angiotensin II signalingBiochemical and Biophysical Research Communications, 2005